Search results
Novavax shares soar on license deal with Sanofi at lofty valuation
Reuters via AOL· 7 days ago(Reuters) -Novavax on Friday said it had struck a licensing deal worth at least $1.2 billion with ...
Novavax shares jump 40% on $1.2 billion licensing deal with Sanofi despite Q1 losses | Invezz
Invezz· 6 days agoNovavax (NASDAQ:NVAX) shares rocketed 40% in premarket trading Friday, driven not only by the...
...Novavax's COVID-19 Vaccine, Inks Multibillion-Dollar Deal With Sanofi And Erases Doubts About Its...
Benzinga· 6 days agoFriday, Novavax Inc (NASDAQ: NVAX) entered a co-exclusive licensing agreement with Sanofi SA SNY for...
Pfizer Settles Zantac Lawsuits, Agrees To $250M Settlement To Reduce Liability: Report - Pfizer...
Benzinga· 14 hours agoIn a bid to settle thousands of lawsuits over its discontinued heartburn drug Zantac, Pfizer Inc....
Biotech Rockets 125% On Sanofi Covid Vaccine Agreement
Investor's Business Daily· 6 days agoNovavax shares shot more than 125% higher Friday on news of a Covid-19 vaccine licensing agreement...
After FTC stalled Sanofi deal, Shionogi secures Maze's Pompe disease drug for $150M
FierceBiotech· 7 days agoIt appears Sanofi’s loss is Shionogi’s gain. Five months after the Federal Trade Commission (FTC) scuttled Sanofi’s attempt to acquire Maze Therapeutics ...
Sanofi strikes $1bn deal with Fulcrum for muscular dystrophy drug
Pharmaceutical Technology via Yahoo Finance· 3 days agoFulcrum Therapeutics has signed a $1bn exclusive licence deal with Sanofi to develop and...
Does Soaring Novavax Stock Have Enough Fuel to Climb Higher? | The Motley Fool
The Motley Fool· 2 days agoThe market was responding to terrific news from Sanofi (NASDAQ: SNY), a global pharmaceutical giant...
Novavax, Sanofi Ink Deal to Commercialize COVID-19 Vaccine to Jointly Produce Combination Shots -...
EconoTimes· 6 days agoNovavax, Inc., a biotechnology company headquartered in Gaithersburg, Maryland, revealed on Friday,...
Sanofi gambles $80M on Fulcrum’s muscular dystrophy drug
BioPharma Dive via Yahoo Finance· 3 days agoThe deal gives the pharma partial rights to a medicine GSK once developed for heart disease but...